Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases
Objectives: Genetic analysis of TNFRSF1A can confirm the diagnosis of tumor necrosis factor receptor-associated periodic syndrome (TRAPS), but interpretation of the pathogenesis of variants of unknown significance is sometimes required. The aim of this study was to evaluate the clinical significance...
Main Authors: | Junko Yasumura, Masaki Shimizu, Tomoko Toma, Masato Yashiro, Akihiro Yachie, Satoshi Okada |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.576152/full |
Similar Items
-
Expression of tumor necrosis factor-alpha and receptor I(P55)in pterygium
by: Bing Wu, et al.
Published: (2014-06-01) -
Understanding the immunopathogenic bases and the clinical approach of the periodic syndrome associated with the tumor necrosis receptor, TRAPS
by: Moreno Zuluaga, Catalina, et al.
Published: (2018-10-01) -
Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies
by: Isabell Lang, et al.
Published: (2018-04-01) -
Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
by: Sujuan Yang, et al.
Published: (2018-04-01) -
Both Tumor Necrosis Factor Receptor Signaling Pathways Contribute to Mortality but not to Splenomegaly in Generalized Lymphoproliferative Disorder
by: Florian Wiede, et al.
Published: (2014-12-01)